Send to

Choose Destination
Crit Rev Oncog. 1998;9(1):1-18.

The involvement of Bcr in leukemias with the Philadelphia chromosome.

Author information

Department of Molecular Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.


In this review, the role of Bcr sequences within Bcr-Abl and the role of the Bcr protein itself in leukemias with the Philadelphia chromosome are discussed. An overview of the oncogenic effects of Bcr-Abl is presented together with Bcr-Abl's effects on several signal transduction pathways. Bcr sequences within Bcr-Abl are known to have an important function in transducing Bcr-Abl's oncogenic signal, yet the role of the Bcr protein encoded by the normal allele is not known. However, several recent findings suggest that Bcr is a conditional negative regulator of Bcr-Abl. From these findings, my colleagues and I have developed a molecular model of the early stage (benign phase) of chronic myelogenous leukemia in which the Bcr protein antagonizes the oncogenic effects of Bcr-Abl.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center